Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Dec;76(6):2134–2138. doi: 10.1172/JCI112218

Monoclonal antibodies to T-2 toxin. In vitro neutralization of protein synthesis inhibition and protection of rats against lethal toxemia.

G Feuerstein, J A Powell, A T Knower, K W Hunter Jr
PMCID: PMC424326  PMID: 4077976

Abstract

A murine monoclonal antibody (15H6) against the trichothecene mycotoxin T-2 was capable of neutralizing the in vitro protein synthesis inhibitory effect of T-2 toxin in human B lymphoblastoid cultures. It was further shown that 15H6 given to rats (250 mg/kg) 30 min before or 15 min after a lethal dose (1 mg/kg) of T-2 toxin conferred 100% survival. A lower dose of 15H6 (125 mg/kg), given 15 min after the lethal dose of T-2 toxin, protected 25% of the rats. An increased time to death and 45% survival was seen in rats given the full dose of 15H6 antibody 60 min after lethal toxin. These data are the first demonstration of effective prophylaxis and therapy for T-2 toxemia.

Full text

PDF
2134

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Butler V. P., Jr Antibodies as specific antagonists of toxins, drugs, and hormones. Pharmacol Rev. 1982 Mar;34(1):109–114. [PubMed] [Google Scholar]
  2. Butler V. P., Jr, Smith T. W., Schmidt D. H., Haber E. Immunological reversal of the effects of digoxin. Fed Proc. 1977 Aug;36(9):2235–2241. [PubMed] [Google Scholar]
  3. CREECH H. J. Chemical and immunological properties of carcinogen-protein conjugates. Cancer Res. 1952 Aug;12(8):557–564. [PubMed] [Google Scholar]
  4. Cannon M., Smith K. E., Carter C. J. Prevention, by ribosome-bound nascent polyphenylalanine chains, of the functional interaction of t-2 toxin with its receptor site. Biochem J. 1976 May 15;156(2):289–294. doi: 10.1042/bj1560289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chiueh C. C., Kopin I. J. Hyperresponsivitiy of spontaneously hypertensive rat to indirect measurement of blood pressure. Am J Physiol. 1978 Jun;234(6):H690–H695. doi: 10.1152/ajpheart.1978.234.6.H690. [DOI] [PubMed] [Google Scholar]
  6. Cundliffe E., Cannon M., Davies J. Mechanism of inhibition of eukaryotic protein synthesis by trichothecene fungal toxins. Proc Natl Acad Sci U S A. 1974 Jan;71(1):30–34. doi: 10.1073/pnas.71.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Curd J., Smith T. W., Jaton J. C., Haber E. The isolation of digoxin-specific antibody and its use in reversing the effects of digoxin. Proc Natl Acad Sci U S A. 1971 Oct;68(10):2401–2406. doi: 10.1073/pnas.68.10.2401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Diamond B. A., Yelton D. E., Scharff M. D. Monoclonal antibodies. A new technique for producing serologic reagents. N Engl J Med. 1981 May 28;304(22):1344–1349. doi: 10.1056/NEJM198105283042208. [DOI] [PubMed] [Google Scholar]
  9. Feuerstein G., Goldstein D. S., Ramwell P. W., Zerbe R. L., Lux W. E., Jr, Faden A. I., Bayorh M. A. Cardiorespiratory, sympathetic and biochemical responses to T-2 toxin in the guinea pig and rat. J Pharmacol Exp Ther. 1985 Mar;232(3):786–794. [PubMed] [Google Scholar]
  10. Gold H. K., Smith T. W. Reversal of ouabain and acetyl strophanthidin effects in normal and failing cardiac muscle by specific antibody. J Clin Invest. 1974 Jun;53(6):1655–1661. doi: 10.1172/JCI107716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hayes A. W. Mycotoxins: a review of biological effects and their role in human diseases. Clin Toxicol. 1980 Aug;17(1):45–83. doi: 10.3109/15563658008985070. [DOI] [PubMed] [Google Scholar]
  12. Hunter K. W., Jr, Brimfield A. A., Miller M., Finkelman F. D., Chu S. F. Preparation and characterization of monoclonal antibodies to the trichothecene mycotoxin T-2. Appl Environ Microbiol. 1985 Jan;49(1):168–172. doi: 10.1128/aem.49.1.168-172.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. JOHNSON H. M., FREY P. A., ANGELOTTI R., CAMPBELL J. E., LEWIS K. H. HAPTENIC PROPERTIES OF PARALYTIC SHELLFISH POISON CONJUGATED TO PROTEINS BY FORMALDEHYDE TREATMENT. Proc Soc Exp Biol Med. 1964 Nov;117:425–430. doi: 10.3181/00379727-117-29599. [DOI] [PubMed] [Google Scholar]
  14. Koch R. B., Desaiah D., Glick B., Subba Rao D. S., Stinson R. Antibody reactivation of kepone inhibited brain ATPase activities. Gen Pharmacol. 1977;8(4):231–234. doi: 10.1016/0306-3623(77)90018-0. [DOI] [PubMed] [Google Scholar]
  15. Lutsky I., Mor N. Experimental alimentary toxic aleukia in cats. Lab Anim Sci. 1981 Feb;31(1):43–47. [PubMed] [Google Scholar]
  16. MAYER C. F. Endemic panmyelotoxicosis in the Russian grain belt. I. The clinical aspects of alimentary toxic aleukia (ATA); a comprehensive review. Mil Surg. 1953 Sep;113(3):173–189. [PubMed] [Google Scholar]
  17. Miller R. A., Maloney D. G., Warnke R., Levy R. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med. 1982 Mar 4;306(9):517–522. doi: 10.1056/NEJM198203043060906. [DOI] [PubMed] [Google Scholar]
  18. Mirocha C. J., Pawlosky R. A., Chatterjee K., Watson S., Hayes W. Analysis for Fusarium toxins in various samples implicated in biological warfare in Southeast Asia. J Assoc Off Anal Chem. 1983 Nov;66(6):1485–1499. [PubMed] [Google Scholar]
  19. Montanaro A., Pirofsky B. Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states. Am J Med. 1984 Mar 30;76(3A):67–72. doi: 10.1016/0002-9343(84)90322-x. [DOI] [PubMed] [Google Scholar]
  20. Peck R. M., Peck E. B. Inhibition of chemically induced neoplasia by immunization with antigenic carcinogen-protein conjugate. Cancer Res. 1971 Nov;31(11):1550–1554. [PubMed] [Google Scholar]
  21. Rosen R. T., Rosen J. D. Presence of four Fusarium mycotoxins and synthetic material in 'yellow rain'. Evidence for the use of chemical weapons in Laos. Biomed Mass Spectrom. 1982 Oct;9(10):443–450. doi: 10.1002/bms.1200091007. [DOI] [PubMed] [Google Scholar]
  22. Schmidt D. H., Butler V. P., Jr Immunological protecion against dixin toxicity. J Clin Invest. 1971 Apr;50(4):866–871. doi: 10.1172/JCI106558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Schoental R., Joffe A. Z., Yagen B. Cardiovascular lesions and various tumors found in rats given T-2 toxin, a trichothecene metabolite of Fusarium. Cancer Res. 1979 Jun;39(6 Pt 1):2179–2189. [PubMed] [Google Scholar]
  24. Smalley E. B. T-2 toxin. J Am Vet Med Assoc. 1973 Dec 1;163(11):1278–1281. [PubMed] [Google Scholar]
  25. Smith T. W., Haber E., Yeatman L., Butler V. P., Jr Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med. 1976 Apr 8;294(15):797–800. doi: 10.1056/NEJM197604082941501. [DOI] [PubMed] [Google Scholar]
  26. Ueno Y., Sato N., Ishii K., Sakai K., Tsunoda H. Biological and chemical detection of trichothecene mycotoxins of Fusarium species. Appl Microbiol. 1973 Apr;25(4):699–704. doi: 10.1128/am.25.4.699-704.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Weaver G. A., Kurtz H. J., Bates F. Y., Chi M. S., Mirocha C. J., Behrens J. C., Robison T. S. Acute and chronic toxicity of T-2 mycotoxin in swine. Vet Rec. 1978 Dec 9;103(24):531–535. doi: 10.1136/vr.103.24.531. [DOI] [PubMed] [Google Scholar]
  28. Wilson C. A., Everard D. M., Schoental R. Blood pressure changes and cardiovascular lesions found in rats given T-2 toxin, a trichothecene secondary metabolite of certain Fusarium microfungi. Toxicol Lett. 1982 Jan;10(1):35–40. doi: 10.1016/0378-4274(82)90264-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES